Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism

Detalhes bibliográficos
Autor(a) principal: Ramos, Marcos Montanha [UNESP]
Data de Publicação: 2022
Outros Autores: Maesta, Izildinha [UNESP], de Araújo Costa, Roberto Antonio [UNESP], Mazeto, Glaucia M.F.S. [UNESP], Horowitz, Neil S., Elias, Kevin M., Braga, Antonio, Berkowitz, Ross S.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.ygyno.2022.01.037
http://hdl.handle.net/11449/230365
Resumo: Objectives: To identify possible clinical factors associated with hyperthyroidism at presentation and to assess post-evacuation thyroid function in women with complete hydatidiform mole (CHM). Methods: This observational study included women with CHM attending a specialized Brazilian center in 2002–2018. Clinical and laboratory data (serum hCG, TSH, fT4) were collected at presentation. Factors associated with hyperthyroidism were assessed by logistic regression. Receiver-operating characteristic curves were built to determine the hCG cutoff for predicting hyperthyroidism at CHM presentation. Post-molar evacuation follow-up included clinical assessment and close thyroid function monitoring. Results: Of 137 CHM patients, 69 (50.3%) had hyperthyroidism of any type (43.5% subclinical, 56.5% overt) at presentation. Uterine fundal height > 16 cm or > gestational age (GA), and theca lutein cysts >6 cm were significantly associated with both subclinical and overt hyperthyroidism. The optimal hCG cutoff for predicting hyperthyroidism was 430,559 IU/L (sensitivity 85.5%, specificity 83.8%). Post-evacuation hyperthyroidism/transient hypothyroidism conversion was observed in 13% of the women with hyperthyroidism at presentation. Among the patients not showing conversion to hypothyroidism, median time for TSH normalization was 2 and 3 weeks for subclinical and overt hyperthyroidism, respectively. In the women with overt hyperthyroidism, fT4 was normalized at 2 weeks. Conclusions: Uterine fundal height > 16 cm, uterine fundal height > GA, theca lutein cysts >6 cm, and hCG >400,000 IU/L at presentation are associated with greater risk of hyperthyroidism and its complications. Close monitoring thyroid function during postmolar follow-up showed that, as thyroid hormones are normalized within 2–3 weeks post-evacuation, the use of beta-blockers or antithyroid drugs can be rapidly discontinued.
id UNSP_fce1f29603a76fe53f079c0eb2afdab1
oai_identifier_str oai:repositorio.unesp.br:11449/230365
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidismHuman chorionic gonadotropinHydatidiform moleHyperthyroidismThyroid functionThyrotoxicosisObjectives: To identify possible clinical factors associated with hyperthyroidism at presentation and to assess post-evacuation thyroid function in women with complete hydatidiform mole (CHM). Methods: This observational study included women with CHM attending a specialized Brazilian center in 2002–2018. Clinical and laboratory data (serum hCG, TSH, fT4) were collected at presentation. Factors associated with hyperthyroidism were assessed by logistic regression. Receiver-operating characteristic curves were built to determine the hCG cutoff for predicting hyperthyroidism at CHM presentation. Post-molar evacuation follow-up included clinical assessment and close thyroid function monitoring. Results: Of 137 CHM patients, 69 (50.3%) had hyperthyroidism of any type (43.5% subclinical, 56.5% overt) at presentation. Uterine fundal height > 16 cm or > gestational age (GA), and theca lutein cysts >6 cm were significantly associated with both subclinical and overt hyperthyroidism. The optimal hCG cutoff for predicting hyperthyroidism was 430,559 IU/L (sensitivity 85.5%, specificity 83.8%). Post-evacuation hyperthyroidism/transient hypothyroidism conversion was observed in 13% of the women with hyperthyroidism at presentation. Among the patients not showing conversion to hypothyroidism, median time for TSH normalization was 2 and 3 weeks for subclinical and overt hyperthyroidism, respectively. In the women with overt hyperthyroidism, fT4 was normalized at 2 weeks. Conclusions: Uterine fundal height > 16 cm, uterine fundal height > GA, theca lutein cysts >6 cm, and hCG >400,000 IU/L at presentation are associated with greater risk of hyperthyroidism and its complications. Close monitoring thyroid function during postmolar follow-up showed that, as thyroid hormones are normalized within 2–3 weeks post-evacuation, the use of beta-blockers or antithyroid drugs can be rapidly discontinued.Postgraduation Program in Tocoginecology Botucatu Medical School UNESP-São Paulo State University, SPBotucatu Trophoblastic Disease Center Clinical Hospital of Botucatu Medical School Department of Gynecology and Obstetrics UNESP-São Paulo State University, SPClinical Hospital of Botucatu Medical School Department of Gynecology and Obstetrics UNESP-São Paulo State University, SPEndocrinology Clinic Department of Internal Medicine Botucatu Medical School UNESP-São Paulo State University, SPNew England Trophoblastic Disease Center Division of Gynecologic Oncology Department of Obstetrics Gynecology and Reproductive Biology Brigham and Women's Hospital Harvard Medical SchoolDepartment of Obstetrics and Gynecology Division of Gynecologic Oncology Brigham and Women's HospitalRio de Janeiro Trophoblastic Disease Center Maternity School of Rio de Janeiro Federal University Antonio Pedro University Hospital Fluminense Federal University, RJPostgraduation Program in Tocoginecology Botucatu Medical School UNESP-São Paulo State University, SPBotucatu Trophoblastic Disease Center Clinical Hospital of Botucatu Medical School Department of Gynecology and Obstetrics UNESP-São Paulo State University, SPClinical Hospital of Botucatu Medical School Department of Gynecology and Obstetrics UNESP-São Paulo State University, SPEndocrinology Clinic Department of Internal Medicine Botucatu Medical School UNESP-São Paulo State University, SPUniversidade Estadual Paulista (UNESP)Harvard Medical SchoolBrigham and Women's HospitalFluminense Federal UniversityRamos, Marcos Montanha [UNESP]Maesta, Izildinha [UNESP]de Araújo Costa, Roberto Antonio [UNESP]Mazeto, Glaucia M.F.S. [UNESP]Horowitz, Neil S.Elias, Kevin M.Braga, AntonioBerkowitz, Ross S.2022-04-29T08:39:29Z2022-04-29T08:39:29Z2022-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.ygyno.2022.01.037Gynecologic Oncology.1095-68590090-8258http://hdl.handle.net/11449/23036510.1016/j.ygyno.2022.01.0372-s2.0-85124383244Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengGynecologic Oncologyinfo:eu-repo/semantics/openAccess2022-04-29T08:39:29Zoai:repositorio.unesp.br:11449/230365Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462022-04-29T08:39:29Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism
title Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism
spellingShingle Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism
Ramos, Marcos Montanha [UNESP]
Human chorionic gonadotropin
Hydatidiform mole
Hyperthyroidism
Thyroid function
Thyrotoxicosis
title_short Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism
title_full Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism
title_fullStr Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism
title_full_unstemmed Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism
title_sort Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism
author Ramos, Marcos Montanha [UNESP]
author_facet Ramos, Marcos Montanha [UNESP]
Maesta, Izildinha [UNESP]
de Araújo Costa, Roberto Antonio [UNESP]
Mazeto, Glaucia M.F.S. [UNESP]
Horowitz, Neil S.
Elias, Kevin M.
Braga, Antonio
Berkowitz, Ross S.
author_role author
author2 Maesta, Izildinha [UNESP]
de Araújo Costa, Roberto Antonio [UNESP]
Mazeto, Glaucia M.F.S. [UNESP]
Horowitz, Neil S.
Elias, Kevin M.
Braga, Antonio
Berkowitz, Ross S.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
Harvard Medical School
Brigham and Women's Hospital
Fluminense Federal University
dc.contributor.author.fl_str_mv Ramos, Marcos Montanha [UNESP]
Maesta, Izildinha [UNESP]
de Araújo Costa, Roberto Antonio [UNESP]
Mazeto, Glaucia M.F.S. [UNESP]
Horowitz, Neil S.
Elias, Kevin M.
Braga, Antonio
Berkowitz, Ross S.
dc.subject.por.fl_str_mv Human chorionic gonadotropin
Hydatidiform mole
Hyperthyroidism
Thyroid function
Thyrotoxicosis
topic Human chorionic gonadotropin
Hydatidiform mole
Hyperthyroidism
Thyroid function
Thyrotoxicosis
description Objectives: To identify possible clinical factors associated with hyperthyroidism at presentation and to assess post-evacuation thyroid function in women with complete hydatidiform mole (CHM). Methods: This observational study included women with CHM attending a specialized Brazilian center in 2002–2018. Clinical and laboratory data (serum hCG, TSH, fT4) were collected at presentation. Factors associated with hyperthyroidism were assessed by logistic regression. Receiver-operating characteristic curves were built to determine the hCG cutoff for predicting hyperthyroidism at CHM presentation. Post-molar evacuation follow-up included clinical assessment and close thyroid function monitoring. Results: Of 137 CHM patients, 69 (50.3%) had hyperthyroidism of any type (43.5% subclinical, 56.5% overt) at presentation. Uterine fundal height > 16 cm or > gestational age (GA), and theca lutein cysts >6 cm were significantly associated with both subclinical and overt hyperthyroidism. The optimal hCG cutoff for predicting hyperthyroidism was 430,559 IU/L (sensitivity 85.5%, specificity 83.8%). Post-evacuation hyperthyroidism/transient hypothyroidism conversion was observed in 13% of the women with hyperthyroidism at presentation. Among the patients not showing conversion to hypothyroidism, median time for TSH normalization was 2 and 3 weeks for subclinical and overt hyperthyroidism, respectively. In the women with overt hyperthyroidism, fT4 was normalized at 2 weeks. Conclusions: Uterine fundal height > 16 cm, uterine fundal height > GA, theca lutein cysts >6 cm, and hCG >400,000 IU/L at presentation are associated with greater risk of hyperthyroidism and its complications. Close monitoring thyroid function during postmolar follow-up showed that, as thyroid hormones are normalized within 2–3 weeks post-evacuation, the use of beta-blockers or antithyroid drugs can be rapidly discontinued.
publishDate 2022
dc.date.none.fl_str_mv 2022-04-29T08:39:29Z
2022-04-29T08:39:29Z
2022-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.ygyno.2022.01.037
Gynecologic Oncology.
1095-6859
0090-8258
http://hdl.handle.net/11449/230365
10.1016/j.ygyno.2022.01.037
2-s2.0-85124383244
url http://dx.doi.org/10.1016/j.ygyno.2022.01.037
http://hdl.handle.net/11449/230365
identifier_str_mv Gynecologic Oncology.
1095-6859
0090-8258
10.1016/j.ygyno.2022.01.037
2-s2.0-85124383244
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Gynecologic Oncology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1799965157445599233